AN-019
CAS: 879507-25-2
Ref. TM-T26625
| 1mg | 274.00 € | ||
| 5mg | 675.00 € | ||
| 10mg | 923.00 € | ||
| 25mg | 1,421.00 € | ||
| 50mg | 1,850.00 € | ||
| 100mg | 2,336.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
Product Information
Name:
AN-019
Synonyms:
- NRC-AN-019
- NRC-019
Description:
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
517.43
Formula:
C25H17F6N5O
Purity:
98.01%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T26625 AN-019
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
